• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于分析癌促凝剂对X因子激活特性的三步显色测定法。

Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant.

作者信息

Mielicki W P, Gordon S G

机构信息

University of Colorado Health Science Center, Denver 80262.

出版信息

Blood Coagul Fibrinolysis. 1993 Jun;4(3):441-6. doi: 10.1097/00001721-199306000-00008.

DOI:10.1097/00001721-199306000-00008
PMID:8329571
Abstract

The cysteine proteinase, cancer procoagulant (CP; EC 3.4.22.26) was isolated from human amnion-chorion and purified by precipitation with polyethylene glycol and either ion exchange or immunoaffinity chromatography. A new, sensitive, three-stage chromogenic assay was developed for determination of CP factor X-activating activity. Using this assay some properties including dose-response, effect of calcium, phospholipid and pH on the activation of factor X by CP was determined. There was an excellent linear correlation (r2 = 0.99) between concentration and the enzymatic activity of CP. The activation of factor X by purified CP was calcium dependent with an optimum calcium concentration of 7 mM. CP was not phospholipid dependent. There was a rather broad pH optimum between pH 6.9 and 7.25 for the activation of factor X by CP.

摘要

半胱氨酸蛋白酶——癌促凝素(CP;EC 3.4.22.26)从人羊膜 - 绒毛膜中分离出来,并通过聚乙二醇沉淀以及离子交换或免疫亲和层析进行纯化。开发了一种新的、灵敏的三阶段显色测定法来测定CP激活因子X的活性。使用该测定法确定了包括剂量反应、钙、磷脂和pH对CP激活因子X的影响等一些特性。CP的浓度与酶活性之间存在极好的线性相关性(r2 = 0.99)。纯化的CP对因子X的激活依赖于钙,最佳钙浓度为7 mM。CP不依赖磷脂。CP激活因子X的最适pH在6.9至7.25之间,范围相当宽。

相似文献

1
Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant.用于分析癌促凝剂对X因子激活特性的三步显色测定法。
Blood Coagul Fibrinolysis. 1993 Jun;4(3):441-6. doi: 10.1097/00001721-199306000-00008.
2
In Vitro Screening of Synthetic Fluorogenic Substrates for Detection of Cancer Procoagulant Activity.体外筛选合成荧光底物检测癌症促凝活性。
Protein J. 2018 Apr;37(2):151-163. doi: 10.1007/s10930-018-9758-x.
3
Effect of divalent ions on the activity of cancer procoagulant.二价离子对癌促凝素活性的影响。
Arch Biochem Biophys. 1994 Oct;314(1):165-70. doi: 10.1006/abbi.1994.1425.
4
Factor X-activating activity from Guerin epithelioma.来自格林上皮瘤的X因子激活活性。
Neoplasma. 1988;35(3):279-84.
5
Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.癌促凝素:一种来自恶性组织的X因子激活剂、肿瘤标志物和生长因子。
Blood Coagul Fibrinolysis. 1997 Mar;8(2):73-86.
6
Cancer procoagulant--CP.癌促凝物质——CP
Rocz Akad Med Bialymst. 1997;42 Suppl 1:110-7.
7
New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors.用于定量癌症促凝活性的新型免疫捕获酶(ICE)检测法:抑制剂研究
Thromb Haemost. 1994 Apr;71(4):456-60.
8
Cysteine proteinase procoagulant from amnion-chorion.来自羊膜-绒毛膜的半胱氨酸蛋白酶促凝剂。
Blood. 1985 Dec;66(6):1261-5.
9
Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.大鼠前列腺肿瘤表达癌促凝素,一种凝血因子X的激活剂。
Comp Med. 2008 Jun;58(3):282-6.
10
comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays.基于凝块的因子 Xa 促凝血磷脂活性测定与显色因子 Xa 促凝血磷脂活性测定的比较。
Am J Clin Pathol. 2012 Feb;137(2):185-92. doi: 10.1309/AJCPGSJ4NHFQMX9W.

引用本文的文献

1
Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke.癌症相关性缺血性卒中的流行病学、病理生理学及管理
Cancers (Basel). 2024 Nov 29;16(23):4016. doi: 10.3390/cancers16234016.
2
In Vitro Screening of Synthetic Fluorogenic Substrates for Detection of Cancer Procoagulant Activity.体外筛选合成荧光底物检测癌症促凝活性。
Protein J. 2018 Apr;37(2):151-163. doi: 10.1007/s10930-018-9758-x.
3
The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.
人癌促凝剂的蛋白水解特征表明,它在激活而非降解水平上促进癌症转移。
Protein J. 2015 Oct;34(5):338-48. doi: 10.1007/s10930-015-9628-8.
4
Arsenic trioxide downregulates cancer procoagulant activity in MCF-7 and WM-115 cell lines in vitro.三氧化二砷在体外下调MCF-7和WM-115细胞系中的癌促凝活性。
Contemp Oncol (Pozn). 2015;19(2):108-12. doi: 10.5114/wo.2014.41390. Epub 2015 May 13.
5
Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation.狼疮抗凝物、华法林及抗凝的替代实验室监测
J Thromb Thrombolysis. 2014 May;37(4):532-5. doi: 10.1007/s11239-013-0949-1.
6
Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.大鼠前列腺肿瘤表达癌促凝素,一种凝血因子X的激活剂。
Comp Med. 2008 Jun;58(3):282-6.
7
The hypercoagulable state of malignancy: pathogenesis and current debate.恶性肿瘤的高凝状态:发病机制与当前争论
Neoplasia. 2002 Nov-Dec;4(6):465-73. doi: 10.1038/sj.neo.7900263.
8
Pathogenesis of thrombosis in patients with malignancy.恶性肿瘤患者血栓形成的发病机制。
Int J Hematol. 2001 Feb;73(2):137-44. doi: 10.1007/BF02981929.